“Mucho” Ado About Nothing?

Linking a mold identified in a sample of recalled yogurt to consumer-reported illnesses may be premature, scientists say.

Written byJyoti Madhusoodanan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

MBIO, SOO CHAN LEE ET AL.A fungus contaminating yogurt containers led to a voluntary recall of certain Chobani products in September 2013. The mold made headlines again last week, when several news outlets reported on a July 8 mBio study in which researchers described a particularly virulent subspecies of Mucor circinelloides isolated from a container of yogurt that was part of the recall.

Joseph Heitman of Duke University in North Carolina and his colleagues analyzed the genome sequence and disease-causing potential of this subspecies of this mold, known as M. circinelloides f. circinelloides, which the researchers dubbed “Mucho” in their paper.

In the researchers’ animal model of infection, Mucho fed to mice did not trigger symptoms like diarrhea or weight loss. But when injected into the bloodstream, the mold caused significant weight loss in some animals. Testing the strain’s interaction with human immune cells, the researchers found that Mucho did not induce the production of inflammatory cytokines, although another subspecies, M. circinelloides f. lusitanicus, did. The failure to trigger chemokines “may contribute to the greater virulence of the M. circinelloides f. circinelloides subspecies,” the authors wrote.

“This is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies